{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:24:34Z","timestamp":1780334674490,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cannabinoids exert dynamic control over many physiological processes including memory formation, cognition and pain perception. In the central nervous system endocannabinoids mediate negative feedback of quantal transmitter release following postsynaptic depolarization. The influence of cannabinoids in the peripheral nervous system is less clear and might have broad implications for the therapeutic application of cannabinoids. We report a novel cannabinoid effect upon the mouse neuromuscular synapse: acutely increasing synaptic vesicle volume and raising the quantal amplitudes. In a mouse model of myasthenia gravis the cannabinoid receptor agonist WIN 55,212 reversed fatiguing failure of neuromuscular transmission, suggesting future therapeutic potential. Our data suggest an endogenous pathway by which cannabinoids might help to regulate transmitter release at the neuromuscular junction.<\/jats:p>","DOI":"10.1038\/s41598-018-22888-4","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T11:45:14Z","timestamp":1520855114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-8050","authenticated-orcid":false,"given":"Marco","family":"Morsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario A.","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfine","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Braet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"22888_CR1","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1113\/jphysiol.2011.220855","volume":"590","author":"BE Alger","year":"2012","unstructured":"Alger, B. E. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. The Journal of physiology 590, 2203\u20132212, https:\/\/doi.org\/10.1113\/jphysiol.2011.220855 (2012).","journal-title":"The Journal of physiology"},{"key":"22888_CR2","doi-asserted-by":"crossref","unstructured":"Mackie, K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of experimental pharmacology, 299\u2013325 (2005).","DOI":"10.1007\/3-540-26573-2_10"},{"key":"22888_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrn3846","volume":"15","author":"M Maccarrone","year":"2014","unstructured":"Maccarrone, M., Guzman, M., Mackie, K., Doherty, P. & Harkany, T. Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nature reviews. Neuroscience 15, 786\u2013801, https:\/\/doi.org\/10.1038\/nrn3846 (2014).","journal-title":"Nature reviews. Neuroscience"},{"key":"22888_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee, R. G. et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacological reviews 62, 588\u2013631, https:\/\/doi.org\/10.1124\/pr.110.003004 (2010).","journal-title":"Pharmacological reviews"},{"key":"22888_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","volume":"29","author":"V Chevaleyre","year":"2006","unstructured":"Chevaleyre, V., Takahashi, K. A. & Castillo, P. E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annual review of neuroscience 29, 37\u201376, https:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.112834 (2006).","journal-title":"Annual review of neuroscience"},{"key":"22888_CR6","doi-asserted-by":"crossref","unstructured":"Howlett, A. C. Cannabinoid receptor signaling. Handbook of experimental pharmacology, 53\u201379 (2005).","DOI":"10.1007\/3-540-26573-2_2"},{"key":"22888_CR7","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","volume":"19","author":"I Katona","year":"1999","unstructured":"Katona, I. et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. The Journal of neuroscience 19, 4544\u20134558 (1999).","journal-title":"The Journal of neuroscience"},{"key":"22888_CR8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","volume":"21","author":"D Robbe","year":"2001","unstructured":"Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O. J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. The Journal of neuroscience 21, 109\u2013116 (2001).","journal-title":"The Journal of neuroscience"},{"key":"22888_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1460-9568.2007.05422.x","volume":"25","author":"Z Newman","year":"2007","unstructured":"Newman, Z. et al. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. The European journal of neuroscience 25, 1619\u20131630, https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05422.x (2007).","journal-title":"The European journal of neuroscience"},{"key":"22888_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2010.02.026","volume":"473","author":"PE Silveira","year":"2010","unstructured":"Silveira, P. E., Silveira, N. A., Morini Vde, C., Kushmerick, C. & Naves, L. A. Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction. Neuroscience letters 473, 97\u2013101, https:\/\/doi.org\/10.1016\/j.neulet.2010.02.026 (2010).","journal-title":"Neuroscience letters"},{"key":"22888_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1124\/jpet.106.116319","volume":"321","author":"E Sanchez-Pastor","year":"2007","unstructured":"Sanchez-Pastor, E., Trujillo, X., Huerta, M. & Andrade, F. Effects of cannabinoids on synaptic transmission in the frog neuromuscular junction. The Journal of pharmacology and experimental therapeutics 321, 439\u2013445, https:\/\/doi.org\/10.1124\/jpet.106.116319 (2007).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"22888_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1021\/ja00730a036","volume":"93","author":"Y Gaoni","year":"1971","unstructured":"Gaoni, Y. & Mechoulam, R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93, 217\u2013224 (1971).","journal-title":"J Am Chem Soc"},{"key":"22888_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0028-3908(76)90135-0","volume":"15","author":"TB Hoekman","year":"1976","unstructured":"Hoekman, T. B., Dettbarn, W. D. & Klausner, H. A. Actions of delta9-tetrahydrocannabinol on neuromuscular transmission in the rat diaphragm. Neuropharmacology 15, 315\u2013319 (1976).","journal-title":"Neuropharmacology"},{"key":"22888_CR14","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G Marsicano","year":"1999","unstructured":"Marsicano, G. & Lutz, B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. The European journal of neuroscience 11, 4213\u20134225 (1999).","journal-title":"The European journal of neuroscience"},{"key":"22888_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1152\/physrev.00019.2008","volume":"89","author":"M Kano","year":"2009","unstructured":"Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. Endocannabinoid-mediated control of synaptic transmission. Physiological reviews 89, 309\u2013380, https:\/\/doi.org\/10.1152\/physrev.00019.2008 (2009).","journal-title":"Physiological reviews"},{"key":"22888_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","volume":"22","author":"E Schlicker","year":"2001","unstructured":"Schlicker, E. & Kathmann, M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends in pharmacological sciences 22, 565\u2013572 (2001).","journal-title":"Trends in pharmacological sciences"},{"key":"22888_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61\u201365, https:\/\/doi.org\/10.1038\/365061a0 (1993).","journal-title":"Nature"},{"key":"22888_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong, J. P. et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071, 10\u201323, https:\/\/doi.org\/10.1016\/j.brainres.2005.11.035 (2006).","journal-title":"Brain Res"},{"key":"22888_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/0269881111400652","volume":"26","author":"ES Onaivi","year":"2012","unstructured":"Onaivi, E. S., Ishiguro, H., Gu, S. & Liu, Q. R. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol 26, 92\u2013103, https:\/\/doi.org\/10.1177\/0269881111400652 (2012).","journal-title":"J Psychopharmacol"},{"key":"22888_CR20","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/j.1476-5381.2011.01405.x","volume":"165","author":"R Baur","year":"2012","unstructured":"Baur, R., Gertsch, J. & Sigel, E. The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. British journal of pharmacology 165, 2479\u20132484, https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01405.x (2012).","journal-title":"British journal of pharmacology"},{"key":"22888_CR21","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.1523\/JNEUROSCI.0977-05.2005","volume":"25","author":"N Lozovaya","year":"2005","unstructured":"Lozovaya, N., Yatsenko, N., Beketov, A., Tsintsadze, T. & Burnashev, N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. The Journal of neuroscience: the official journal of the Society for Neuroscience 25, 7499\u20137506, https:\/\/doi.org\/10.1523\/JNEUROSCI.0977-05.2005 (2005).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"22888_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","volume":"126","author":"RA Ross","year":"1999","unstructured":"Ross, R. A. et al. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. British journal of pharmacology 126, 665\u2013672, https:\/\/doi.org\/10.1038\/sj.bjp.0702351 (1999).","journal-title":"British journal of pharmacology"},{"key":"22888_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli, D. et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS drug reviews 12, 21\u201338, https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00021.x (2006).","journal-title":"CNS drug reviews"},{"key":"22888_CR24","doi-asserted-by":"publisher","first-page":"7972","DOI":"10.1073\/pnas.85.21.7972","volume":"85","author":"EJ Bowman","year":"1988","unstructured":"Bowman, E. J., Siebers, A. & Altendorf, K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proceedings of the National Academy of Sciences of the United States of America 85, 7972\u20137976 (1988).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"22888_CR25","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.1073\/pnas.1001695107","volume":"107","author":"SW Fong","year":"2010","unstructured":"Fong, S. W. et al. TGF-beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size. Proceedings of the National Academy of Sciences of the United States of America 107, 13515\u201313519, https:\/\/doi.org\/10.1073\/pnas.1001695107 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"22888_CR26","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1523\/JNEUROSCI.22-23-10267.2002","volume":"22","author":"S Karunanithi","year":"2002","unstructured":"Karunanithi, S., Marin, L., Wong, K. & Atwood, H. L. Quantal size and variation determined by vesicle size in normal and mutant Drosophila glutamatergic synapses. The Journal of neuroscience: the official journal of the Society for Neuroscience 22, 10267\u201310276 (2002).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"22888_CR27","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine, B. M., Milani, M. & Kaminski, H. J. Myasthenia gravis: past, present, and future. The Journal of clinical investigation 116, 2843\u20132854, https:\/\/doi.org\/10.1172\/JCI29894 (2006).","journal-title":"The Journal of clinical investigation"},{"key":"22888_CR28","doi-asserted-by":"publisher","unstructured":"Plomp, J. J., Morsch, M., Phillips, W. D. & Verschuuren, J. J. Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models. Experimental neurology, https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.007 (2015).","DOI":"10.1016\/j.expneurol.2015.01.007"},{"key":"22888_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/archneur.1975.00490500030002","volume":"32","author":"MA Kamenskaya","year":"1975","unstructured":"Kamenskaya, M. A., Elmqvist, D. & Thesleff, S. Guanidine and neuromuscular transmission. II. Effect on transmitter release in response to repetitive nerve stimulation. Archives of neurology 32, 510\u2013518 (1975).","journal-title":"Archives of neurology"},{"key":"22888_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.psyneuen.2011.09.017","volume":"37","author":"E Heyman","year":"2012","unstructured":"Heyman, E. et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans\u2013possible implications for reward and depression. Psychoneuroendocrinology 37, 844\u2013851, https:\/\/doi.org\/10.1016\/j.psyneuen.2011.09.017 (2012).","journal-title":"Psychoneuroendocrinology"},{"key":"22888_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00421-012-2495-5","volume":"113","author":"DA Raichlen","year":"2013","unstructured":"Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A. & Gerdeman, G. L. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol 113, 869\u2013875, https:\/\/doi.org\/10.1007\/s00421-012-2495-5 (2013).","journal-title":"Eur J Appl Physiol"},{"key":"22888_CR32","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1124\/mol.104.003558","volume":"67","author":"S Mukhopadhyay","year":"2005","unstructured":"Mukhopadhyay, S. & Howlett, A. C. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions. Molecular pharmacology 67, 2016\u20132024, https:\/\/doi.org\/10.1124\/mol.104.003558 (2005).","journal-title":"Molecular pharmacology"},{"key":"22888_CR33","doi-asserted-by":"publisher","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","volume":"287","author":"L Callen","year":"2012","unstructured":"Callen, L. et al. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. The Journal of biological chemistry 287, 20851\u201320865, https:\/\/doi.org\/10.1074\/jbc.M111.335273 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"22888_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neulet.2016.06.014","volume":"628","author":"AE Gaydukov","year":"2016","unstructured":"Gaydukov, A. E., Bogacheva, P. O. & Balezina, O. P. Calcitonin gene-related peptide increases acetylcholine quantal size in neuromuscular junctions of mice. Neuroscience letters 628, 17\u201323, https:\/\/doi.org\/10.1016\/j.neulet.2016.06.014 (2016).","journal-title":"Neuroscience letters"},{"key":"22888_CR35","doi-asserted-by":"publisher","first-page":"c3363","DOI":"10.1136\/bmj.c3363","volume":"340","author":"Z Kmietowicz","year":"2010","unstructured":"Kmietowicz, Z. Cannabis based drug is licensed for spasticity in patients with MS. Bmj 340, c3363, https:\/\/doi.org\/10.1136\/bmj.c3363 (2010).","journal-title":"Bmj"},{"key":"22888_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher, P., Batkai, S. & Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological reviews 58, 389\u2013462, https:\/\/doi.org\/10.1124\/pr.58.3.2 (2006).","journal-title":"Pharmacological reviews"},{"key":"22888_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrc3247","volume":"12","author":"G Velasco","year":"2012","unstructured":"Velasco, G., Sanchez, C. & Guzman, M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12, 436\u2013444, https:\/\/doi.org\/10.1038\/nrc3247 (2012).","journal-title":"Nat Rev Cancer"},{"key":"22888_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","volume":"16","author":"V Di Marzo","year":"2015","unstructured":"Di Marzo, V., Stella, N. & Zimmer, A. Endocannabinoid signalling and the deteriorating brain. Nature reviews. Neuroscience 16, 30\u201342, https:\/\/doi.org\/10.1038\/nrn3876 (2015).","journal-title":"Nature reviews. Neuroscience"},{"key":"22888_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/dta.1529","volume":"6","author":"PJ Robson","year":"2014","unstructured":"Robson, P. J. Therapeutic potential of cannabinoid medicines. Drug testing and analysis 6, 24\u201330, https:\/\/doi.org\/10.1002\/dta.1529 (2014).","journal-title":"Drug testing and analysis"},{"key":"22888_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","volume":"237","author":"M Morsch","year":"2012","unstructured":"Morsch, M., Reddel, S. W., Ghazanfari, N., Toyka, K. V. & Phillips, W. D. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors. Experimental neurology 237, 286\u2013295, https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.034 (2012).","journal-title":"Experimental neurology"},{"issue":"Pt 1","key":"22888_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","volume":"500","author":"SJ Wood","year":"1997","unstructured":"Wood, S. J. & Slater, C. R. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. The Journal of physiology 500(Pt 1), 165\u2013176 (1997).","journal-title":"The Journal of physiology"},{"key":"22888_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1113\/jphysiol.2004.077685","volume":"562.3","author":"OL Gerv\u00e1sio","year":"2005","unstructured":"Gerv\u00e1sio, O. L. & Phillips, W. D. Increased ratio of rapsyn to ACh receptor stabilizes postsynaptic receptors at the mouse neuromuscular synapse. J Physiol 562(3), 673\u2013685 (2005).","journal-title":"J Physiol"},{"key":"22888_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ydbio.2007.02.008","volume":"305","author":"OL Gervasio","year":"2007","unstructured":"Gervasio, O. L., Armson, P. F. & Phillips, W. D. Developmental increase in the amount of rapsyn per acetylcholine receptor promotes postsynaptic receptor packing and stability. Developmental biology 305, 262\u2013275, https:\/\/doi.org\/10.1016\/j.ydbio.2007.02.008 (2007).","journal-title":"Developmental biology"},{"key":"22888_CR44","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3748\/wjg.v16.i23.2851","volume":"16","author":"E Wisse","year":"2010","unstructured":"Wisse, E. et al. Fixation methods for electron microscopy of human and other liver. World J Gastroenterol 16, 2851\u20132866 (2010).","journal-title":"World J Gastroenterol"},{"key":"22888_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nprot.2011.439","volume":"7","author":"JC Tapia","year":"2012","unstructured":"Tapia, J. C. et al. High-contrast en bloc staining of neuronal tissue for field emission scanning electron microscopy. Nat Protoc 7, 193\u2013206, https:\/\/doi.org\/10.1038\/nprot.2011.439 (2012).","journal-title":"Nat Protoc"},{"key":"22888_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0006-8993(88)90203-X","volume":"475","author":"GQ Fox","year":"1988","unstructured":"Fox, G. Q. A morphometric analysis of synaptic vesicle distributions. Brain Res 475, 103\u2013117 (1988).","journal-title":"Brain Res"},{"key":"22888_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2818.1973.tb03807.x","volume":"98","author":"D Froesch","year":"1973","unstructured":"Froesch, D. A simple method to estimate the true diameter of synaptic vesicles. J Microsc 98, 85\u201389 (1973).","journal-title":"J Microsc"},{"key":"22888_CR48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.21371","volume":"63","author":"RN Cole","year":"2008","unstructured":"Cole, R. N., Reddel, S. W., Gerv\u00e1sio, O. L. & Phillips, W. D. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann Neurol 63, 782\u2013789 (2008).","journal-title":"Ann Neurol"},{"key":"22888_CR49","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","volume":"588.17","author":"RN Cole","year":"2010","unstructured":"Cole, R. N. et al. Patient autoantibodies deplete postsynaptic Muscle Specific Kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice. J Physiol (Lond) 588(17), 3217\u20133229 (2010).","journal-title":"J Physiol (Lond)"},{"key":"22888_CR50","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","volume":"591","author":"M Morsch","year":"2013","unstructured":"Morsch, M., Reddel, S. W., Ghazanfari, N., Toyka, K. V. & Phillips, W. D. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. The Journal of physiology 591, 2747\u20132762, https:\/\/doi.org\/10.1113\/jphysiol.2013.251827 (2013).","journal-title":"The Journal of physiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22888-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22888-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22888-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:30:08Z","timestamp":1671593408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22888-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22888-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4685"}}